A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
Clinical trial NCT05668988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05668988
- Sponsor
- Dizal Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2026-01-16
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.